These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21247552)

  • 21. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological prognostic factors predicting para-aortic lymph node metastasis in patients with endometrioid uterine cancer.
    Karube Y; Fujimoto T; Takahashi O; Nanjyo H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2010 Aug; 118(2):151-4. PubMed ID: 20621776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting pelvic lymph node metastasis in endometrial carcinoma.
    Kamura T; Yahata H; Shigematsu T; Ogawa S; Amada S; Kaku T; Nakano H
    Gynecol Oncol; 1999 Mar; 72(3):387-91. PubMed ID: 10053111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic factors of stage III endometrial carcinoma].
    Li J; Kong WM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):198-200. PubMed ID: 19537039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of prognostic factors in patients with endometrial cancer and lymph node excision].
    Vavra N; Sevelda P; Schemper M; Kucera H; Weghaupt K
    Gynakol Rundsch; 1991; 31 Suppl 2():258-60. PubMed ID: 1790946
    [No Abstract]   [Full Text] [Related]  

  • 29. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
    Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
    Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.
    Shah C; Johnson EB; Everett E; Tamimi H; Greer B; Swisher E; Goff B
    Gynecol Oncol; 2005 Dec; 99(3):564-70. PubMed ID: 16246402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma.
    Nofech-Mozes S; Ackerman I; Ghorab Z; Ismiil N; Thomas G; Covens A; Khalifa MA
    Am J Clin Pathol; 2008 Jun; 129(6):912-7. PubMed ID: 18480008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of systematic lymphadenectomy and adjuvant radiation in early-stage endometrioid uterine cancer.
    Jeong NH; Lee JM; Lee JK; Kim MK; Kim YJ; Cho CH; Kim SM; Park SY; Park CY; Kim KT
    Ann Surg Oncol; 2010 Nov; 17(11):2951-7. PubMed ID: 20556522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
    Sonoda Y; Zerbe M; Smith A; Lin O; Barakat RR; Hoskins WJ
    Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node status did not significantly improve the predictability of survival in patients with clinically early-stage endometrial cancer.
    Bae HS; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT; Kang S
    Int J Gynecol Cancer; 2014 Oct; 24(8):1449-54. PubMed ID: 25180462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: results of a multicenter study.
    Gemer O; Gdalevich M; Voldarsky M; Barak F; Ben Arie A; Schneider D; Levy T; Anteby EY; Lavie O
    Eur J Surg Oncol; 2009 Aug; 35(8):865-9. PubMed ID: 19013746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
    Garuti G; De Giorgi O; Sambruni I; Cellani F; Luerti M
    Gynecol Oncol; 2001 Jun; 81(3):408-13. PubMed ID: 11371130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
    Chen SL; Hoehne FM; Giuliano AE
    Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.